Lantern Pharma LTRN
NASDAQ LTRN
$0.69 +0.05 (+8.12%)
As of: Oct 20, 2026 · 3:39 PM EDT

Lantern Pharma (LTRN) Non-Current Debt (2020)

Updated

Lantern Pharma's Non-Current Debt was $108,500 in Q2 2020.

Analysis

Lantern Pharma (LTRN) Non-Current Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,147.40 Bn 1,115.99 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 623.11 Bn 541.63 Bn 17.26 Bn 37.34 Bn
3 AbbVie 509.31 Bn 482.42 Bn 12.70 Bn 62.48 Bn
4 Merck 365.84 Bn 320.22 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.62 Bn 235.30 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.65 Bn 191.05 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.97 Bn 118.61 Bn 10.94 Bn 60.50 Bn
10 Lantern Pharma 8.62 Mn -27.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 108,500.00
API Access

Lantern Pharma Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=LTRN&period=max&api_key=YOUR_API_KEY